People spend an average of over 7 hours/day on displays.
SunInLyf Bio's patented TheraVID technology is a therapeutic display technology that will enable devices with video displays to regenerate retinal mitochondria cells to improve vision and other health factors by emitting controlled wavelengths of 600nm-1400nm Red, Near-IR & IR health promoting photobiomodulation (PBMh) visible and non-visible light towards the viewers eyes and face while using a video display device. The PBM light increases the production of Adenosine Triphosphate (ATP) which is the fuel needed by all living cells. With this ATP fuel, the cells heal and regenerate.
How TheraVID Works:
- Visible & Non-Visible Photobiomodulation (PBM) light is emitted from a portion of the display device at certain times of the day for controlled periods of time during screen time
- 670nm PBM light increases the production of ATP in the retina to stimulate retinal cellular regeneration
- Other beneficial wavelengths of PBM light are emitted to increase the production of ATP in the body, resulting in other beneficial health factors
Recent clinical studies show that 3 minutes of PBM treatments of specific wavelengths of Red light (such as 670nm) before noon will regenerate retinal mitochondria cells and improve vision. Other wavelengths of PBM light have long been used and proven to promote other health factors to the human body such as lowering blood pressure, improved resting heart rate and more. As a result, the visionary innovators at SunInLyf Bio have been building a portfolio of patents to enable the video display devices we spend so many hours a day using, to deliver these health promoting wavelengths of PBM light to combat the negative effects of display overuse by delivering health promoting PBM wavelengths of light.
TheraVID Features & Benefits:
• Supports healthier vision
• Improves physical health and wellness
• Supports immune system
• Takes your temperature
• Increase your productivity
Antibiotic resistance poses a significant global threat.
SunInLyf Bio's patented RegeneWAVE technology uses controlled, DNA safe 180nm – 400nm forms of UV light to fight infection. In some equipment & devices the UV is combined with 600nm – 1400nm Red and IR photobiomodulation “PBM” wavelengths of light to help accelerate healing while fighting the infection. The PBM light increases the production of Adenosine Triphosphate (ATP) which is the fuel needed by all living cells. With this ATP fuel, the cells heal and regenerate faster.
How RegenWAVE Works:
- UV light is used to kill viral/bacterial infections
- IR light is used to induce a localized fever effect to slow
pathogen reproduction without increasing metabolic demand
- Red/IR light is used to increase the production of ATP via Photobiomodulation“PBM” wavelengths of light to accelerate healing
Recent studies have proven that certain wavelengths of UV light are DNA safe to humans while still being able to kill viruses and bacteria at a slower rate than non-healthy UV wavelengths of light. As a result, the visionary innovators at SunInLyf Bio have been building a portfolio of patents to enable manufacturers to integrate these safe, anti-infective wavelengths of light into medical equipment, devices and wearables to fight and kill infections, along with adding healthy PBM wavelengths of Red and IR light to accelerate healing .deliver these health promoting wavelengths of PBM light to combat the negative effects of display overuse by delivering health promoting PBM wavelengths of light.
RegeneWave technology will enable manufacturers to develop next generation medical devices and equipment never before imagined. In and out-patient RegeneWave equipment and devices, including wearable devices that use healthy wavelengths of light to fight infection and accelerate healing.
RegeneWAVE Features & Benefits:
• Emits DNA Safe UV Light Waves To Fight Infection
• Emits Red/IR To Fight Infections & Accelerate Healing
• Slows Pathogen Growth/Reproduction
• Self-Administration Product Options
• Fast & Effective
• Safe & Painless
"Studies in the past decade indicate that insufficient sun exposure may be responsible for 340,000 deaths in the United States and 480,000 deaths in Europe per year, and an increased incidence of breast cancer, colorectal cancer, hypertension, cardiovascular disease, metabolic syndrome, multiple sclerosis, Alzheimer’s disease, autism, asthma, type 1 diabetes and myopia.”
Reference
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400257/
The next major evolutionary step for health and wellness will be centered around delivering visible and non-visible healthy wavelengths of light in new and unique ways through consumer electronics, medical devices and our infrastructure.
SunInLyf Bio's innovators have been ahead of this curve. Improving health and wellness with new devices that emit healthy wavelengths of light similar to what is delivered by the sun, is at the core of SunInLyf Bio’s mission.
By continuing to innovate, grow and license SunInLyf Bio's leading patent portfolio, we will enable industry pioneers and market leaders in various industries to bring to market a host of new and advanced health and wellness products never before envisioned in consumer electronics, medical devices and other consumer products. New products and therapeutic methods that will be used to deliver health and wellness to our lives in ways that do not exist today.
SunInLyf Bio's patent portfolio will become an industry leading portfolio of over 100 foundational patents that will drive significant value for our investors and strategic licensing partners.
Email us at info@suninlyfbio.com or call at (847) 904-1180
Copyright © 2024 SuninLyf Bio LLC - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.